Cargando…
Toward refining Alzheimer's disease into overlapping subgroups
Alzheimer's disease (AD) is an age‐related neurodegenerative disorder characterized by progressive anterograde amnesia, cerebral atrophy, and eventual death. Current treatment has limited efficacy and cannot decelerate the disease progression. Clinical trials targeting the removal of the neurop...
Autores principales: | Hascup, Erin R., Hascup, Kevin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453148/ https://www.ncbi.nlm.nih.gov/pubmed/32885025 http://dx.doi.org/10.1002/trc2.12070 |
Ejemplares similares
-
Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022) -
Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics
During Alzheimer’s Disease Progression
por: Findley, Caleigh A., et al.
Publicado: (2019) -
Does SARS-CoV-2 infection cause chronic neurological complications?
por: Hascup, Erin R., et al.
Publicado: (2020) -
Amyloid-β(42) stimulated hippocampal lactate release is coupled to glutamate uptake
por: Hascup, Erin R., et al.
Publicado: (2022) -
Growth Hormone and Aging: New Findings
por: Bartke, Andrzej, et al.
Publicado: (2021)